Unrecognized Myocardial Infarctions Have a 10-Year Mortality Rate Comparable to Clinically-Recognized Infarctions

According to a new study published in the Journal of American Medical Association, unrecognized myocardial infarction (UMI) detected by cardiac magnetic resonance (CMR) was associated with equivalent all-cause mortality as…

Ahmed Younes, M.D.

Atrial Fibrillation in a Cancer Setting: Understanding Unmet Needs in Cardio-Oncology

A new study by Neal et al. demonstrated that although patients with atrial fibrillation (AF) and cancer were less likely to see a cardiologist or fill anticoagulant prescriptions, cardiology involvement…

Sudarshana Datta, M.D.

From Barbershops to Churches: Are Community-Based Interventions the Best Way to Engage Vulnerable Populations?

The FAITH study (Faith-Based Approaches in the Treatment of Hypertension) has portrayed how a community-based lifestyle intervention delivered in churches can lead to a significantly greater reduction in systolic BP…

Sudarshana Datta, M.D.

Variability in Metabolic Parameters: A Prognostic Surrogate Marker for MI, Stroke and Death?

A study by Mee Kyoung Kim and her colleagues published in Circulation has shown that there is a graded association between the number of high variability parameters like fasting blood…

Mahshid Mir

GLP-1 Receptor Agonist Albiglutide Demonstrates ‘Harmonious’ Cardiovascular Outcomes in Type 2 Diabetics

The results of the recently published Harmony-Outcomes study in The Lancet, led by Professor Stefano Del Prato, University of Pisa, Italy and Professor John McMurray, University of Glasgow, UK, have…

Farima Kahe

Anticoagulant and Antiplatelet Therapy in Stented Patients with Atrial Fibrillation

In an article published in the Journal of the American College of Cardiology, authored by Caroline Sindet-Pederson, MSc, and colleagues in the Department of Cardiology at Copenhagen University Hospital Herlev…

Sudarshana Datta, M.D.

Periprocedural loading dose of Atorvastatin reduces MACE in patients with ACS undergoing PCI: Is this a Pleiotropic effect?

A study by Lopes and his colleagues published in JAMA Cardiology has shown that in patients with ACS undergoing PCI, periprocedural loading doses of atorvastatin appeared to reduce the rate…

Sudarshana Datta, M.D.

Same Day Discharge Following Elective PCI Proven Both Safe and Economical

An observational cross-sectional cohort study by Amin et al. suggested that greater and more consistent use of same-day discharge(SDD) following elective percutaneous coronary intervention (PCI) is the United States, could…

Sudarshana Datta, M.D.

Top 10 Cardiology Now Stories for September

1. COAPT  Demonstrates the Benefit of Transcatheter Mitral-Valve Repair Using MitraClip in Patients with Heart Failure The trial demonstrated that transcatheter mitral valve approximation using the MitraClip, on a background of…

Ahmed Younes, M.D.

Vascular Video Series Part 9: AHA’s Goal for Reducing Cardiovascular Death by 20% in 2020

This video is supported by an unrestricted educational grant.

Tarek Nafee, M.D.

Midterm Survival Rates High in Asymptomatic Aortic Stenosis, Early Intervention Useful in Severe Cases

A study by published in JAMA cardiology indicated that the potential benefit of early intervention must be considered in high-risk AS patients. Cases of asymptomatic AS followed up in heart…

Sudarshana Datta, M.D.

Does the Wearable Cardioverter-Defibrillator Benefit MI Patients?

In patients with acute myocardial infarction (MI) and a left ventricular ejection fraction (LVEF) equal or less than 35%, the use of wearable cardioverter defibrillator early after the MI did…

Ahmed Younes, M.D.

Portico TAVR study demonstrates low rates of stroke, death at 1 year

Results from the Portico 1 study were presented during a late-breaking session at the Transcatheter Cardiovascular Therapeutics conference in San Diego showing that transcatheter aortic valve replacement (TAVR) with the…

Sudarshana Datta, M.D.

Vascular Video Series Part 8: What the Future Holds for Antithrombotic Therapies

This video is supported by an unrestricted educational grant.

Tarek Nafee, M.D.

Pulmonary Artery Denervation Improves Pulmonary HTN in Heart Failure

The findings of the Pulmonary artery denervation (PADN) trial, presented at the TCT conference on Sept 23rd have shown that PADN is associated with significant improvements in hemodynamic and clinical…

Sudarshana Datta, M.D.

Vascular Video Series Part 7: Biology and Pathways of Treatment in Atherosclerotic Patients

This video is supported by an unrestricted educational grant.

Tarek Nafee, M.D.

Highlights of TCT 2018

The results of many interesting trials were presented at the TCT conference 2018 held in San Diego, California.

Ahmed Younes, M.D.

Tiered Approach for Management of Angina Patients With No Obstructive CAD Shows Benefit

For angina patients without obstructive coronary artery disease (CAD), adjunctive testing of coronary vascular function during coronary angiography followed by medical therapy targeted to the findings improved angina outcomes, according…

Sudarshana Datta, M.D.

‘Rota Regret’ Makes Training in High-Speed Rotablation A Necessity, for Interventionalists Dealing with Heavily Calcified Coronary Lesions

The results of PREPARE-CALC trial, presented at TCT 2018, have shown that among patients with severely calcified coronary lesions, the routine use of upfront high-speed rotational atherectomy (RA) increases stent…

Sudarshana Datta, M.D.

Encouraging Outcomes in ABSORB IV Pave the Way for Polymeric Coronary Bioresorbable Vascular Scaffolds

In the long saga of ABSORB trials, the ABSORB IV trial presented at the TCT conference 2018 showed that polymeric coronary bioresorbable vascular scaffolds (BVS) were non-inferior to cobalt-chromium-based Xience…

Sudarshana Datta, M.D.